25021-317-40 : NDC 2026 Code

25021-317-40 : Labetalol Hydrochloride ( Labetalol Hydrochloride )

Additionally :

You can get information about “25021-317-40” NDC code in 25021-317-40 in HTML format

HTML | 25021-317-40 in TXT (Plain Text) format

TXT | 25021-317-40 in PDF (Portable Document Format)

PDF | 25021-317-40 in XML format

XML formats.

NDC Code : 25021-317-40 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "25021-317-40",
    "PackageDescription": "1 VIAL in 1 CARTON (25021-317-40)  &gt; 40 mL in 1 VIAL",
    "NDC11Code": "25021-0317-40",
    "ProductNDC": "25021-317",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Labetalol Hydrochloride",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Labetalol Hydrochloride",
    "DosageFormName": "INJECTION, SOLUTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20220901",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA214533",
    "LabelerName": "Sagent Pharmaceuticals",
    "SubstanceName": "LABETALOL HYDROCHLORIDE",
    "StrengthNumber": "5",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2022-11-17",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20220901",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}